Literature DB >> 8898107

Clustered localization of oligomeric Nef protein of human immunodeficiency virus type 1 on the cell surface.

Y Fujii1, K Otake, Y Fujita, N Yamamoto, Y Nagai, M Tashiro, A Adachi.   

Abstract

We studied human immunodeficiency virus type 1 (HIV-1) Nef protein biochemically and histologically. HIV-1 Nef, derived from baculosystem and from cells infected with HIV-1, formed homomeric monomers, dimers, trimers, and further polymers. These oligomers were non-covalently associated. In cells infected with HIV-1, Nef molecules were clustered at the cell surface as well as cytoplasm. Our previous results have indicated that the Nef on the surface of cells infected with HIV-1 is cytotoxic against uninfected CD4+ T cells. Thus, it is very likely that the HIV-1-mediated cytotoxic reaction is due, at least in part, to the clustered localization of oligomeric Nef on the cell surface.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8898107     DOI: 10.1016/0014-5793(96)01048-4

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  12 in total

1.  HIV-1 envelope induces activation of caspase-3 and cleavage of focal adhesion kinase in primary human CD4(+) T cells.

Authors:  C Cicala; J Arthos; A Rubbert; S Selig; K Wildt; O J Cohen; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

2.  Validation of a novel secretion modification region (SMR) of HIV-1 Nef using cohort sequence analysis and molecular modeling.

Authors:  Patrick E Campbell; Olexandr Isayev; Syed A Ali; William W Roth; Ming-Bo Huang; Michael D Powell; Jerzy Leszczynski; Vincent C Bond
Journal:  J Mol Model       Date:  2012-05-30       Impact factor: 1.810

3.  Activation of the T-cell receptor signaling pathway by Nef from an aggressive strain of simian immunodeficiency virus.

Authors:  W Luo; B M Peterlin
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

4.  Molecular interactions of human immunodeficiency virus type 1 with primary human oral keratinocytes.

Authors:  Edward A Acheampong; Zahida Parveen; Lois W Muthoga; Vivian Wasmuth-Peroud; Mehrnush Kalayeh; Adnan Bashir; Robert Diecidue; Muhammad Mukhtar; Roger J Pomerantz
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

5.  Human Immunodeficiency virus type 1 Nef potently induces apoptosis in primary human brain microvascular endothelial cells via the activation of caspases.

Authors:  Edward A Acheampong; Zahida Parveen; Lois W Muthoga; Mehrnush Kalayeh; Muhammad Mukhtar; Roger J Pomerantz
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

6.  Characterization and molecular basis of the oligomeric structure of HIV-1 nef protein.

Authors:  S Arold; F Hoh; S Domergue; C Birck; M A Delsuc; M Jullien; C Dumas
Journal:  Protein Sci       Date:  2000-06       Impact factor: 6.725

7.  Genetic characterization of HIV type 1 Nef-induced vesicle secretion.

Authors:  Syed A Ali; Ming-Bo Huang; Patrick E Campbell; William W Roth; Tamika Campbell; Mahfuz Khan; Gale Newman; Francois Villinger; Michael D Powell; Vincent C Bond
Journal:  AIDS Res Hum Retroviruses       Date:  2010-02       Impact factor: 2.205

8.  Contribution of nonneutralizing vaccine-elicited antibody activities to improved protective efficacy in rhesus macaques immunized with Tat/Env compared with multigenic vaccines.

Authors:  Ruth H Florese; Thorsten Demberg; Peng Xiao; LaRene Kuller; Kay Larsen; L Ebonita Summers; David Venzon; Aurelio Cafaro; Barbara Ensoli; Marjorie Robert-Guroff
Journal:  J Immunol       Date:  2009-03-15       Impact factor: 5.422

9.  HIV inhibits endothelial reverse cholesterol transport through impacting subcellular Caveolin-1 trafficking.

Authors:  Shanshan Lin; Peter E Nadeau; Ayalew Mergia
Journal:  Retrovirology       Date:  2015-07-15       Impact factor: 4.602

Review 10.  The activity of Nef on HIV-1 infectivity.

Authors:  Stéphane Basmaciogullari; Massimo Pizzato
Journal:  Front Microbiol       Date:  2014-05-20       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.